Evidence map›Paper›PMID 37398408›Full record

ArticlemedRxiv : the preprint server for health sciences2023

Genome-wide Association Identifies Novel Etiological Insights Associated with Parkinson's Disease in African and African Admixed Populations.

Mie Rizig, Sara Bandres-Ciga, Mary B Makarious, Oluwadamilola Ojo, Peter Wild Crea, Oladunni Abiodun, Kristin S Levine, Sani Abubakar, Charles Achoru, Dan Vitale and 69 more

Open access · greenAbstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 17 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

79 authors at 20 institutions in 5 countries.

Mie RizigDepartment of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London WC1N 3BG, UK.
Sara Bandres-CigaCenter for Alzheimer's and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA, 20814.
Mary B MakariousUCL Movement Disorders Centre, University College London, London, WC1N 3BG, UK.
Oluwadamilola OjoCollege of Medicine, University of Lagos, Idi Araba, Lagos State, Nigeria.
Peter Wild CreaCenter for Alzheimer's and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA, 20814.
Oladunni AbiodunGeneral Hospital, Isolo, Lagos State, Nigeria.
Kristin S LevineCenter for Alzheimer's and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA, 20814.
Sani AbubakarAhmadu Bello University, Zaria, Kaduna State, Nigeria.
Charles AchoruJos University Teaching Hospital, Jos, Plateau State, Nigeria.
Dan VitaleData Tecnica International, Washington, DC, USA.
Olaleye AdenijiFederal Medical Centre, Abeokuta, Ogun State, Nigeria.
Osigwe AgabiCollege of Medicine, University of Lagos, Idi Araba, Lagos State, Nigeria.
Mathew J KoretskyCenter for Alzheimer's and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA, 20814.
Uchechi AgulannaLagos University Teaching Hospital, Idi Araba, Lagos State, Nigeria.
Deborah A HallDepartment of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA.
Rufus AkinyemiNeuroscience and Ageing Research Unit, Institute for Advanced Medical Research and Training, College of Medicine, University of Ibadan, Ibadan, Oyo State, Nigeria.
Tao XieDepartment of Neurology, University of Chicago Medicine, Chicago, Illinois, USA.
Mohammed AliFederal Teaching Hospital Gombe, Gombe State, Nigeria.
Ejaz A ShamimHuman Motor Control Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA.
Ifeyinwa Ani-OshekuAsokoro District Hospital, Asokoro, Abuja, Nigeria.
Mahesh PadmanabanDepartment of Neurology, University of Chicago Medicine, Chicago, Illinois, USA.
Owotemu ArigbodiDelta State University, Abraka, Delta State, Nigeria.
David G StandaertDepartment of Neurology, University of Alabama at Birmingham, Birmingham, AL, USA.
Abiodun BelloUniversity of Ilorin Teaching Hospital, Ilorin, Kwara State, Nigeria.
Marissa DeanDepartment of Neurology, University of Alabama at Birmingham, Birmingham, AL, USA.
Cyril EramehIrrua Specialist Teaching Hospital, Irrua, Edo State, Nigeria.
Inas ElsayedFaculty of Pharmacy, University of Gezira, Wadmadani, 20, Sudan.
Temitope FarombiUniversity College Hospital, Ibadan, Oyo State, Nigeria.
Olaitan OkunoyeDepartment of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London WC1N 3BG, UK.
Michael FawaleObafemi Awolowo University, Ile-Ife, Osun State, Nigeria.
Kimberley J BillingsleyCenter for Alzheimer's and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA, 20814.
Frank ImarhiagbeUniversity of Benin, Benin City, Edo State, Nigeria.
Pilar Alvarez JerezDepartment of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London WC1N 3BG, UK.
Emmanuel IwuozoBenue State University, Makurdi, Benue State, Nigeria.
Breeana BakerCenter for Alzheimer's and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA, 20814.
Morenikeji KomolafeObafemi Awolowo University, Ile-Ife, Osun State, Nigeria.
Laksh MalikCenter for Alzheimer's and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA, 20814.
Paul NwaniNnamdi Azikiwe University Teaching Hospital, Nnewi, Anambra State, Nigeria.
Kensuke DaidaCenter for Alzheimer's and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA, 20814.
Ernest NwazorRivers State University Teaching Hospital, Port Harcourt, Rivers State, Nigeria.
Abigail Miano-BurkhardtCenter for Alzheimer's and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA, 20814.
Yakub NyandaitiUniversity of Maiduguri Teaching Hospital, Maiduguri, Borno State, Nigeria.
Zih-Hua FangGerman Center for Neurodegenerative Diseases (DZNE), Tuebingen, Germany.
Yahaya ObiaboFederal University of Health Sciences, Otukpo, Benue State, Nigeria.
Jillian H KlussLaboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.
Olanike OdeniyiGeneral Hospital, Lagos Island, Lagos State, Nigeria.
Dena HernandezLaboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.
Francis OdiaseUniversity of Benin, Benin City, Edo State, Nigeria.
Nahid TayebiMedical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA.
Francis OjiniCollege of Medicine, University of Lagos, Idi Araba, Lagos State, Nigeria.
Ellen SidranksyMedical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA.
Gerald OnwuegbuzieUniversity of Abuja, Abuja, Federal Capital Territory, Nigeria.
Andrea M D'SouzaMedical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA.
Godwin OsaigbovoJos University Teaching Hospital, Jos, Plateau State, Nigeria.
Bahafta BerheMedical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA.
Nosakhare OsemwegieUniversity of Port Harcourt, Port Harcourt, Rivers State, Nigeria.
Xylena ReedCenter for Alzheimer's and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA, 20814.
Olajumoke OshinaikeLagos State University College of Medicine, Ikeja, Lagos State, Nigeria.
Hampton LeonardCenter for Alzheimer's and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA, 20814.
Folajimi OtubogunFederal Medical Center, Ebute Metta, Lagos State, Nigeria.
Chelsea X AlvaradoCenter for Alzheimer's and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA, 20814.
Shyngle OyakhireNational Hospital, Abuja, Federal Capital Territory, Nigeria.
Simon OzommaUniversity of Calabar Teaching Hospital, Calabar, Cross River State, Nigeria.
Sarah SamuelUniversity of Maiduguri Teaching Hospital, Maiduguri, Borno State, Nigeria.
Funmilola TaiwoUniversity College Hospital, Ibadan, Oyo State, Nigeria.
Kolawole WahabUniversity of Ilorin Teaching Hospital, Ilorin, Kwara State, Nigeria.
Yusuf ZubairNational Hospital, Abuja, Federal Capital Territory, Nigeria.
Hirotaka IwakiCenter for Alzheimer's and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA, 20814.
Jonggeol Jeffrey KimCenter for Alzheimer's and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA, 20814.
Huw R MorrisDepartment of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London WC1N 3BG, UK.
John HardyDepartment of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London WC1N 3BG, UK.
Mike NallsData Tecnica International, Washington, DC, USA.
Karl Heilbron23andMe, Inc., Sunnyvale, CA, USA.
Lucy Norcliffe-Kaufmann23andMe, Inc., Sunnyvale, CA, USA.
Disease Research Network, International Parkinson’s Disease Genomics Consortium - Africa (IPDGC Africa), Black and African American Connections to Parkinson’s Disease (BLAAC PD) Study Group, the 23andMe Research Team
Cornelis BlauwendraatCenter for Alzheimer's and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA, 20814.
Henry HouldenDepartment of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London WC1N 3BG, UK.
Andrew SingletonCenter for Alzheimer's and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA, 20814.
Njideka OkubadejoCollege of Medicine, University of Lagos, Idi Araba, Lagos State, Nigeria.
National Institutes of Health · USNational Hospital for Neurology and Neurosurgery · GBUniversity of Lagos · NG23andMe (United States) · USBenue State University · NGJos University Teaching Hospital · NGLagos State Health Service Commission · NGNational Hospital Abuja · NGObafemi Awolowo University · NGUniversity College Hospital, Ibadan · NGUniversity of Alabama at Birmingham · USUniversity of Benin · NGUniversity of Chicago · USUniversity of Maiduguri · NGAhmadu Bello University · NGDelta State University · NGFederal Medical Centre · NGGerman Center for Neurodegenerative Diseases · DEGombe State University · NGIrrua Specialist Teaching Hospital · NG

Funding

Genome wide SNP analysis in Parkinson's diseaseZIAAG000949 · NIA · NATIONAL INSTITUTE ON AGING · PI SINGLETON, ANDREW · 2009 to 2024
$12.6M
Project 3: LRRK2 mediated macrophage responses in PDP50NS108675 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI WEST, ANDREW B · 2018 to 2022
$9.9M
Genome wide SNP analysis in Parkinson's diseaseZ01AG000949 · NIA · NATIONAL INSTITUTE ON AGING · PI SINGLETON, ANDREW B · 2006 to 2008
$2.6M
MIDCAREER AWARD IN PATIENT ORIENTED RESEARCH ON AGINGK24AG000949 · NIA · YALE UNIVERSITY · PI INOUYE, SHARON K. · 1999 to 2009
$1.4M
UAB Research Education Program for Residents and Fellows in NeuroscienceR25NS079188 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI STANDAERT, DAVID G. · 2012 to 2022
$1.1M
Intramural NIH HHS Z01 AG000949Intramural NIH HHS ZIA AG000949NIA NIH HHS K24 AG000949NINDS NIH HHS P50 NS108675NINDS NIH HHS R25 NS079188
6 · The paper itself

Abstract

Background: Understanding the genetic mechanisms underlying diseases in ancestrally diverse populations is a critical step towards the realization of the global application of precision medicine. The African and African admixed populations enable mapping of complex traits given their greater levels of genetic diversity, extensive population substructure, and distinct linkage disequilibrium patterns. Methods: Here we perform a comprehensive genome-wide assessment of Parkinson's disease (PD) in 197,918 individuals (1,488 cases; 196,430 controls) of African and African admixed ancestry, characterizing population-specific risk, differential haplotype structure and admixture, coding and structural genetic variation and polygenic risk profiling. Findings: We identified a novel common risk factor for PD and age at onset at the Interpretation: The present study identifies a novel African-ancestry genetic risk factor in Research in Context: Evidence Before this Study: Our current understanding of Parkinson's disease (PD) is disproportionately based on studying populations of European ancestry, leading to a significant gap in our knowledge about the genetics, clinical characteristics, and pathophysiology in underrepresented populations. This is particularly notable in individuals of African and African admixed ancestries. Over the last two decades, we have witnessed a revolution in the research area of complex genetic diseases. In the PD field, large-scale genome-wide association studies in the European, Asian, and Latin American populations have identified multiple risk loci associated with disease. These include 78 loci and 90 independent signals associated with PD risk in the European population, nine replicated loci and two novel population-specific signals in the Asian population, and a total of 11 novel loci recently nominated through multi-ancestry GWAS efforts.Nevertheless, the African and African admixed populations remain completely unexplored in the context of PD genetics. Added Value of this Study: To address the lack of diversity in our research field, this study aimed to conduct the first genome-wide assessment of PD genetics in the African and African admixed populations. Here, we identified a genetic risk factor linked to PD etiology, dissected African-specific differences in risk and age at onset, characterized known genetic risk factors, and highlighted the utility of the African and African admixed risk haplotype substructure for future fine-mapping efforts. We identified a novel disease mechanism via expression changes consistent with decreased Implications of all the Available Evidence: We nominate a novel signal impacting

Identifiers

PMID37398408
PMCPMC10312852
OpenAlexW4372782409

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.